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Objective: This pilot study aims to identify white matter (WM) tract abnormalities
in Autism Spectrum Disorders (ASD) toddlers and pre-schoolers by Diffusion Tensor
Imaging (DTI), and to correlate imaging findings with clinical improvement after early
interventional and Applied Behavior Analysis (ABA) therapies by Verbal Behavior
Milestones Assessment and Placement Program (VB-MAPP).
Methods: DTI scans were performed on 17 ASD toddlers/pre-schoolers and seven
age-matched controls. Nine ASD patients had follow-up MRI 12 months following early
intervention and ABA therapy. VB-MAPP was assessed and compared at diagnosis,
6 and 12 months after therapies. Tract-Based Spatial Statistics (TBSS) was used to
measure fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial
(RD) diffusivity.
Results: VB-MAPP scores improved at 6 and 12 months after early intervention
and ABA therapy compared to scores at baseline. TBSS analysis showed significant
FA decrease and/or RD increase in ASD patients before therapy vs. controls in
inferior fronto-occipital fasciculi, uncinate fasciculi, left superior fronto-occipital fasciculus,
forceps minor, left superior fronto-occipital fasciculus, right superior longitudinal
fasciculus, corona radiate bilaterally, and left external capsule. A significantly FA increase
in 21 tracts and ROIs is reported in post- vs. pre-therapy DTI analysis.
Conclusion: DTI findings highlighted ASD patient WM abnormalities at diagnosis and
confirmed the benefits of 12 months of early intervention and ABA therapy on clinical and
neuro imaging outcomes.
Keywords: diffusion tensor imaging (DTI), autism spectrum disorder (ASD), applied behavior analysis (ABA)
therapy, ASD interventional therapies, VB-MAPP assessment
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INTRODUCTION
Autism spectrum disorders (ASD) are
neurodevelopmental disorders characterized by repetitive
and restrictive behaviors, and language and socialization deficits
in early childhood (1). Increased parent/physician awareness
coupled with improved assessment tools, lead to better diagnosis,
and higher prevalence [1/40 children in the United States (2) and
1/66 children in Lebanon] (3). Parents typically have concerns in
the first year of life, but diagnosis of ASD is made between the
ages of 18–24 months.
Genetic and environmental factors, including prenatal, and
perinatal complications are important contributors to ASD risk
(4). An abnormal developmental trajectory of the brain (5), early
brain development and changes in gray and WM structures and
connectivity are also associated with emergence of symptoms
(6). WM tracts structural integrity and change in myelination
contribute to the pathogenesis of ASD shown in several age-
groups (7, 8). In addition to lack of knowledge regarding
myelination in toddlers with ASD, contradictions abound in the
literature as to which specific areas are implicated.
New tools for early diagnosis and prediction in high-risk
populations, based on MRI data have been identified (8). DTI
offers insight into the micro-structural organization and integrity
ofWM (9). DTI studies performed on infants and young children
report increased FA in frontal tracts, left uncinate fasciculus,
inferior longitudinal fasciculus and corpus callosum at 6 months
of age (7). Longitudinal studies by Wolff et al. and Solso
et al. in infants and toddlers state that ASD has a dynamic
neural pathology (7, 10). Abnormal fractional anisotropy (FA)
in ASD has been reported in pathways affecting socio-emotional
processing in the limbic system, language areas, temporal
lobes, and higher order functions involving the frontal cortex
(11). These regions identify childhood ASD as a disorder of
fronto-temporal-limbic circuitry (12). Additionally, decreased
FA, increased mean and radial diffusivities (MD, RD) in the
corpus callosum (CC) in young ASD patients (10, 13), are
probably associated with lower intelligence quotients and slower
processing rates.
The standard of care approach for toddlers and pre-
schoolers with ASD currently includes integration in nurseries
as well as a customized curriculum involving regular sessions
of psychomotor, speech, occupational and Applied Behavior
Analysis therapies. ABA is based on the science of learning and
behavior (14). In general, the objectives of ABA in the treatment
of children with autism are to increase desirable behaviors,
decrease undesirable behaviors, and increase skill acquisition in
every area of development (language and communication, social,
academic, daily living skills, motor skills, etc.). Since the 1960s,
therapists have been applying behavior analysis to help children
with autism and related developmental disorders. Several papers
provide evidence of the effectiveness of ABA treatment for
children with autism (15). Dawson et al. (16) conducted the first
trial to demonstrate the effect of early behavioral intervention
on brain activity. The results of EEG in ASD patients between
18 and 30 months compared to age-matched controls suggest
that early interventional therapies are associated with normalized
brain activity patterns related to social attention and engagement,
and that these normalized brain activity patterns are correlated
with improvements in social behavior.
The clinical effect of these therapies in ASD patients is
documented in the literature (17). However, its biologic
impact on WM microstructure has not been addressed. The
aims of this study are to characterize the impact of early
intervention/behavioral therapies on WM integrity in specific
brain regions in autistic toddlers and pre-schoolers. In this
pilot study, ASD patients underwent MRI scans and behavioral
assessment using The Verbal Behavior Milestones Assessment
and Placement Program (VB-MAPP), a comprehensive
evaluation which is designed to identify the existing language
and related developmental skills for children with autism or
other developmental disabilities, before and after therapy,
to explore the positive impact of therapies on imaging and
clinical outcomes.
METHODS
Subjects
Recruitment of participants took place at the American university
of Beirut Medical Center (AUBMC), between 2014 and 2018.
Participants were toddlers and pre-schoolers between the age of
18 months and 4 years.
Children with contraindications to anesthesia or history of
neurological disorders, infection, ischemia, or genetic disorders
were excluded. Diagnosis of patients was based on the Diagnostic
and Statistical Manual of Mental Disorders (DSM-V) criteria
by two experienced pediatric neurologists at AUBMC. The
Autism Diagnostic Observation Schedule (ADOS) conducted by
behavioral and speech therapists helped confirm the diagnosis.
The group of ASD children was heterogeneous with inclusion
of all severity groups (mild, moderate, severe). Asperger and
pervasive developmental disorder-not otherwise specified (PDD-
NOS) cases were not included.
Additionally, normal developing age-matched controls were
recruited at the radiology department of our institution. Children
presenting with any symptom requiring imaging by MRI
including headaches, suspected new onset seizures, trauma,
ophthalmic problems, or orbital disease, hearing or inner ear
problems, neck masses, cervical neck pain, or malformation were
included. All controls were subjected to initial clinical evaluation
by their treating physician and categorized as neuro-typical
children prior to being approached and enrolled in this study.
Subjects with prematurity (<36 weeks gestation), any medical
condition affecting brain development, any motor deficits,
sensory impairment, psychiatric disorder as well as adopted
children with no available prenatal and perinatal history were
excluded. In addition, the presence of any abnormal findings
on brain MRI such as tumors or congenital malformations or a
leukodystrophy, resulted in withdrawing subjects from the study.
Behavioral Assessment and Early
Intervention Therapies
In ASD group 1 (G1), once the diagnosis of ASD was established,
patients underwent a Verbal Behavior Assessment and Placement
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Program (VB-MAPP) assessment. This is a criterion-referenced
evaluation battery that guides therapy and serves to follow-
up progression of skills in children with ASD and language
delays (18) VB-MAPP assesses developmental communicative
milestones. Patients underwent VB-MAPP evaluations at initial
diagnosis, 6 and 12 months after initiation of ABA behavior
analysis and early intervention therapies.
Treatment consisted of attending nursery school 5 days
a week, 6–10 h of ABA sessions in homes and/or nurseries
per week, in addition to 1 h each of speech, occupational
and psychomotor therapy. Patients underwent two MRI
examinations, one before beginning early intervention and the
second repeated 12 months after therapy. ASD patients re-
scanned 12 months later were referred to as group 2 (G2).
Image Acquisition
MRI image acquisition was performed on a 3 Tesla Phillips
Ingenia MR system (Philips Healthcare, Best, The Netherlands).
All subjects underwent sedation for the scan. Oral chloral hydrate
was used in r 4/7 children in the control group and 4 children
in ASD group at baseline, or deep sedation administered by
an anesthesiologist for remaining controls and ASD patients
before and after therapies). The conventional MR imaging
protocol consisted in the acquisition of 3D sagittal T1 turbo
field echo sequence without gadolinium injection with echo
time/repetition time (TE/TR) = 3.8/8.3ms, flip angle = 8◦, field
of view (FOV) of 240 × 240mm, matrix of 240 × 222 and a
spatial resolution of 1 × 0.94×0.94 mm3. A 3D (FLAIR) fluid
attenuated inversion recovery image with echo time/repetition
time/inversion time = 347/4,800/1,660ms, FOV = 220 ×
220mm, slice thickness = 1mm (with no gap), and a matrix of
224× 224.
DTI data were acquired using a multi-slice echo-planar
spin-echo sequence (TR/TE=11279.5/106ms). Seventy-five
contiguous, 2mm thick, axial slices were acquired covering the
whole brain. The protocol comprised 32 non-collinear diffusion
gradient directions with b values of 0 and 1,000 s/mm2. A 1.75×
1.75 × 2 mm3 resolution was achieved with a matrix size of 112
× 112 over a FOV of 128× 128 mm.
DTI data was visually inspected (by SH and RH) in
order to detect artifacts arising from subject motion or
scanner malfunction and to confirm the lack of visually
detectable abnormalities.
Data Processing
The FMRIB Software Library (FSL) (19) was used for the analysis
of DTI data. An Eddy current correction followed by a non-
brain voxels extraction was applied. Diffusivity maps (FA, axial
diffusivity (AD), RD, and MD) were generated and checked for
presence of significant residual motion or other artifacts.
FA maps were then grouped for the tract-based spatial
statistics (TBSS) analysis (20). All subject data were initially
non-linearly aligned to one of the subjects’ space. Since the
study cohort consists of children, the common template used
in FSL was thereby not adapted. To this end, all subjects were
registered to one another in order to find the most “typical”
subject to use as a target image to align all others. All registered
FA maps were averaged to obtain a mean FA image that was
later used to generate a mean skeleton of the major WM tracts
on which all aligned subjects FA data were projected. The
resulting data were then fed into a voxel-wise statistical analysis
(described below), performed to identify significant differences.
For better assessment, TBSS was also applied to the other
diffusivitymaps (AD, RD, andMD). DTImetrics differences were
evaluated between the patient group before treatment (G1) and
the control group and between patients themselves before and
after treatment (using age and time interval between both scans
as well as sex of the patients as covariates).
Voxel-wise analysis was based on a non-parametric approach
using the permutation test theory with a standard generalized
linear model design matrix. The permutation testing was
performed using the Randomize module of FSL (21).
The threshold-free cluster enhancement (TFCE) option of
Randomize was applied on the resulting statistical maps that
were corrected for multiple comparisons. The anatomical
location of significant clusters was identified based on WM
atlases (JHU ICBM-DTI81 White Mater Labels and JHU
White-Matter Tractography Atlas) in FSL. In order to confirm
the voxel-wise analysis results, quantitative values of diffusion
metrics were extracted from 48 regions of interest (ROI) and
21 fiber-bundles of the JHU atlases, by multiplying atlas labels
with the TBSS skeleton obtained from all 24 subjects (22). ROI
data extraction was solely performed on the significant masks
obtained from the TBSS analysis. To this end, a 5% value of
significant voxels per total number of voxels per ROI was set as a
threshold to consider the ROI significant.
Ethical Approval
This study protocol was approved by the Institutional Review
Board of AUBMC.Written informed consent was obtained for all
participants from parents and/or legal guardians in accordance
with the Declaration of Helsinki.
Statistical Analysis
The Statistical Package for Social Sciences (SPSS), version
24.0 was used for data cleaning, management, and analyses.
Descriptive statistics including mean, median, range, standard
deviation, and frequencies with percentages were calculated.
Statistical analysis was performed using the Mann Whitney
for continuous variables and Fisher exact test for categorical
variables. The Wilcoxon Signed rank test was used to compare
the VB-MAPP scores at diagnosis, after 6 and 12 months post-
therapy. Results are presented with a 95% Confidence interval
(CI). Significant P < 0.05.
RESULTS
Demographics
Newly diagnosed ASD patients (G1, n= 17) had a median age of
2.9 years (1.9–4.7). Nine patients repeated the MRI examination
12 months after initiating therapy (G2) and had a median age
of 4.2 years (2.1–6). Seven control subjects were included in the
study with a median age of 3.3 years (1.6–4.7). No significant
differences in age between males and females were observed
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TABLE 1 | Demographics of normal pediatric controls, 17 patients with ASD at diagnosis (G1), and nine patients with ASD after 12-months of therapy (G2).
Normal controls
(NC) N = 7
Autism patients at diagnosis
(G 1) N = 17
Autism patients
after 12 months of therapies N = 9 (G2)
NC & G1
Age (years) Median (min-max) Median (min-max) Median (min-max) P-value
3.3 (1.6–4.7) 2.9 (1.9–4.7) 4.2 (2.1–6.0) 0.227a
Sex Frequency (%) Frequency (%) Frequency (%) P-value
Males 4 (57.1) 12 (70.6) 5 (55) 0.647b
Females 3 (42.9) 5 (29.4) 4 (45)
aMann-Whitney test; bFisher’s exact test.
between G1 ASD patients and normal controls (p= 0.261) as well
as between G2 and G1 ASD patients (p= 1) (Table 1).
VB-MAPP Scores at Diagnosis, Six and
Twelve Months Following Initiation of
Therapies in the ASD Group
VB-MAPP scores were closely monitored in the ASD patients.
Sixteen of the seventeen enrolled ASD patients underwent VB-
MAPP testing with only one patient refusing the assessment.
VB-MAPP scores at the time of initial ASD diagnosis had a
median score of 13.75 (IQ = 4–63.59) and a mean of 17.5 ±
14.6. All 16 patients completed their 6-months VB-MAPP score
assessment with a median of 21.25 (IQ = 10–88.78) and mean
of 34.1 ± 24.9. Two patients have not yet completed their 12-
months assessment. The median VB-MAPP scores at 12 months
after therapies was 70 (IQ = 13–99.86) with a mean of 55.47 ±
29.9. This confirms significant improvement in VB-MAPP scores
at 6 months of early interventional and ABA therapies compared
to baseline scores (p < 0.0001) and at 12 months of therapies
compared to initial scores at diagnosis (p < 0.0001) (Figure 1A).
This clinical improvement was documented when comparing
VB-MAPP scores of each patient individually (Figure 1B).
TBSS Analyses
Comparison Between ASD Groups (G1/G2) and
Neurotypical Controls
TBSS analysis showed significant differences in FA and RD
when comparing ASD patients at baseline (G1) to the control
group. FA was significantly decreased in ASD patients compared
to controls in left and right inferior fronto-occipital fasciculi,
left and right uncinate fasciculi, left superior fronto-occipital
fasciculus, left anterior corona radiata, and left external capsule.
RD was significantly increased in ASD patients compared to
controls in the forceps minor, left superior fronto-occipital
fasciculus, right inferior fronto-occipital fasciculus, left and
right uncinate fasciculi, right superior longitudinal fasciculus
(temporal part), right superior longitudinal fasciculus, left and
right anterior corona radiata, and left external capsule. No
significant differences were observed in AD and MD between
both groups (Table 2).
Paired Comparison Between ASD Subgroups at
Diagnosis (G1) and 12 Months Post-therapies (G2)
TBSS analysis was also performed on the ASD group (n= 9) after
completing a 12-months treatment period and had underwent
pre- and post-treatment MRIs. Age and time in between the
two scans were used as a covariate. A significant increase in
FA was observed in the post-treatment ASD group compared
to baseline values in the following areas: left and right superior
longitudinal fasciculi/left and right inferior fronto-occipital
fasciculi/left and right corticospinal tracts/left and right anterior
thalamic radiations/forceps major/forceps minor/left external
capsule/left and right anterior and posterior corona radiate/right
sagittal stratum/left and right posterior and anterior limbs of
internal capsule/left cerebral peduncle/right fornix cres/stria
terminalis/splenium/genu, and body of the corpus callosum (CC)
(Table 3). No significant changes were observed for AD, RD,
and MD.
DISCUSSION
This study examines WM differences in ASD using DTI, which
enables quantitation of WM maturation in toddlers and pre-
schoolers and depicts axonal abnormalities providing symptom
interpretation in ASD. DTI/TBSS analysis performed between
the ASD group pre-therapy and control subjects highlighted a
decreased FA in the frontal regions, the anterior corona radiata,
and the external capsule (Figure 2A). Increased RD was also
reported in multiple regions involving several frontal pathways,
the inferior corona radiata, the left external capsule and the
forceps minor (Figure 2B). FA was found to be significantly
higher in ASD patients after therapy as compared to themselves
before therapy in 21 tracts and ROIs (Table 3).
The significant difference between the ASD patients at
baseline and neurotypical controls may explain the delay
in neural connectivity between various brain regions, which
in turn contributes to emotional lability, restricted social
communication, language delay, and other symptoms observed
in ASD. Decreased FA could be the outcome of several
mechanisms including decreasedmyelination/axonal density and
abnormal axonal organization (23), whereas increased RD, may
reflect differences in myelination, axonal diameter or packing
density and/or glial densities (24). These results are in line with
previous reports of reduced FA in the WM of ASD patients
indicating lower coherence of directionality in several regions
such as the prefrontal cortices, temporal-parietal junctions,
fronto-temporal/fronto-parietal tracts and the CC (23, 25). A
study evaluating development of WM tracts in infants at high
risk for ASD shows increased FA in several tracts from 6 till
24 months of age in participants without ASD symptoms, and
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FIGURE 1 | (A) VB-MAPP median scores of 16 ASD patients at diagnosis, 14 ASD patients after 6 and 12 months of interventional therapies. The score increased
from a median of 13.75 [4-63.59] at diagnosis to reach 21.25 [10-88.78] and 70 [13-99.86] at 6 and 12 months, respectively. Wilcoxon Signed Ranks test was done
to detect differences between the 3 scores at diagnosis and at 6 months (p < 0.0001), score at 6 months and 12 months (p < 0.0001). (B) Progression of VB-MAPP
scores and improvement of values at diagnosis and over 12 months of therapy in ASD patients (14/16 cases with assessments at diagnosis, 6 and 12 months after
therapy, 2/16 cases with first and second assessment at diagnosis and at 6 months).
TABLE 2 | White matter tracts with lower values (>5%, p < 0.05) in fractional anisotropy (FA) and/or higher values in radial diffusivity (RD) in ASD patients at diagnosis
(G1) compared to controls by TBSS.
White matter tracts Fractional anisotropy Radial diffusivity
% of significant
FA regional
differences
FA controls
(N = 7)
Mean ± SD
FA patients at diagnosis
(N = 17)
Mean ± SD
% of significant
RD regional
differences
RD controls
(N = 7)
Mean ± SD
RD patients at
diagnosis (N = 17)
Mean ± SD
JHU ATLAS
LUF 10.41 0.406 ± 0.025 0.373 ± 0.027 8.83 0.649 ± 0.030 0.687 ± 0.033
RUF 7.91 0.439 ± 0.026 0.392 ± 0.020 11.61 0.630 ± 0.031 0.678 ± 0.028
LIFOF 5.94 0.421 ± 0.017 0.391 ± 0.028 5.49 0.635 ± 0.022 0.675 ± 0.047
Fminor 4.85 0.538 ± 0.031 0.506 ± 0.036 5.57 0.535 ± 0.039 0.585 ± 0.054
RSLF* 0 0.534 ± 0.027 0.491 ± 0.039 13.42 0.548 ± 0.030 0.613 ± 0.049
ICBM ATLAS
LSFOF* 13.02 0.455 ± 0.049 0.419 ± 0.035 0 0.548 ± 0.045 0.583 ± 0.043
RIFOF 11.84 0.458 ± 0.019 0.441 ± 0.036 13.68 0.639 ± 0.022 0.676 ± 0.052
LACR 10.06 0.410 ± 0.024 0.375 ± 0.034 9.24 0.634 ± 0.032 0.686 ± 0.055
LEC 5.76 0.376 ± 0.021 0.354 ± 0.025 3.49 0.658 ± 0.023 0.683 ± 0.032
RACR 4.85 0.402 ± 0.023 0.375 ± 0.024 7.74 0.639 ± 0.032 0.681 ± 0.045
RSLF 1.32 0.429 ± 0.018 0.399 ± 0.028 6.10 0.611 ± 0.020 0.651 ± 0.043
LUF, Left uncinate fasciculus; RUF, Right uncinate fasciculus; LIFOF, Left inferior fronto-occipital fasciculus; RSLF, Right superior longitudinal fasciculus; Fminor, Forceps minor; LSFOF*,
Left superior fronto-occipital fasciculus (may be part of anterior internal capsule); RIFOF, Right inferior fronto-occipital fasciculus; LACR, Left anterior corona radiata; LEC, Left external
Capsule; RACR, Right anterior corona cadiata; RSLF*, Right superior longitudinal fasciculus.
higher values than in ASD-confirmed patients (7). Other studies,
however, demonstrate increased FA and decreased RD in children
with ASD in multiple regions including frontal pathways, CC,
posterior limb of internal capsule, external capsule, and the
superior longitudinal fasciculus (10, 26). Symptoms of ASD
imply over-connectivity and increase in myelination in tracts
connecting different brain regions, thus, altering the coherence of
axon orientation in those children. At present, there is no definite
pathophysiological process that explains the neurodevelopmental
delay in ASD toddlers.
This study goes beyond comparing controls and ASD patients
at diagnosis. It employed VB-MAPP and DTI over time, to
measure the effectiveness of interventions on developmental
outcomes and white matter integrity in ASD patients. Nine
of seventeen patients (G2) underwent re-scanning after 12
months of ABA and other interventional therapies. TBSS analysis
was performed on G2 scans (from post-therapy patients) and
compared to pre-therapy scans.
Pre- and post-therapy analysis established improvement of
WM integrity through the documented increase in FA (Table 3).
WM pathways rapidly develop during the first years of life
(27, 28). In the first 5 years of life, a gradual increase in FA and
decrease in MD is observed. After this age, FA changes are less
conspicuous and are attributed to completion of mechanisms
of myelination and alterations in intra-axonal microstructure,
caliber, and orientation (28–31). FA values in normal developing
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TABLE 3 | White matter tracts with higher values (>5%, p < 0.05) in fractional anisotropy (FA) in ASD patients after 12 months of therapies (G2) compared to patients at
diagnosis (G1) by TBSS.
White matter tracts % of significant FA regional
differences post-therapy
FA patients at diagnosis (N = 9)
Mean ± SD
FA patients after therapies (N = 9)
Mean ± SD
JHU ATLAS
RIFOF 32.268 0.405 ± 0.033 0.428 ± 0.031
LCST 32.086 0.544 ± 0.026 0.566 ± 0.026
Fminor 31.589 0.493 ± 0.039 0.515 ± 0.039
RCST 30.898 0.561 ± 0.028 0.584 ± 0.028
RATR 26.682 0.366 ± 0.020 0.381 ± 0.024
RSLF 18.736 0.382 ± 0.024 0.394 ± 0.029
LIFOF 16.225 0.383 ± 0.030 0.408 ± 0.033
Fmajor 14.101 0.416 ± 0.044 0.449 ± 0.043
LATR 9.172 0.371 ± 0.023 0.391 ± 0.028
LSLF 7.330 0.414 ± 0.068 0.438 ± 0.069
ICBM ATLAS
BCC 46.51 0.592 ± 0.040 0.612 ± 0.032
LRLIC 43.21 0.506 ± 0.033 0.531 ± 0.036
RRLIC 42.23 0.483 ± 0.040 0.495 ± 0.041
RPCR 39.79 0.412 ± 0.026 0.424 ± 0.029
LACR 38.42 0.365 ± 0.039 0.393 ± 0.042
RPTR* 36.94 0.489 ± 0.046 0.522 ± 0.041
RACR 34.09 0.368 ± 0.029 0.392 ± 0.032
GCC 30.66 0.638 ± 0.040 0.657 ± 0.037
LPCR 26.32 0.421 ± 0.037 0.442 ± 0.034
RALIC 21.69 0.476 ± 0.019 0.497 ± 0.024
LEC 21.25 0.346 ± 0.022 0.370 ± 0.018
RSLF 15.26 0.394 ± 0.026 0.405 ± 0.028
LPLIC 14.37 0.613 ± 0.027 0.636 ± 0.026
SCC 13.31 0.679 ± 0.015 0.694 ± 0.020
Fx (cres)/ RST 10.56 0.432 ± 0.037 0.441 ± 0.038
LCP 9.90 0.561 ± 0.019 0.591 ± 0.022
RPLIC 9.77 0.626 ± 0.027 0.642 ± 0.020
RSS* 6.10 0.432 ± 0.038 0.458 ± 0.0.40
LSLF 5.77 0.396 ± 0.021 0.041 ± 0.023
LSLF, Left Superior longitudinal fasciculus; RSLF, Right Superior longitudinal fasciculus; Fminor, Forceps minor; LIFOF, Left Inferior fronto-occipital fasciculus; Fmajor, Forceps major;
RIFOF, Right Inferior fronto-occipital fasciculus; LCST, Left corticospinal tract; RCST, Right corticospinal tract; LATR, left anterior thalamic radiation; BCC, Body of corpus callosum; RATR,
Right anterior thalamic radiation; LEC, Left external capsule; Fx, Fornix (cres); LCP, Left Cerebral peduncle, LACR, Left anterior corona radiata; RACR, Right anterior corona radiata;
RSS*, Right sagittal stratum (inferior longitudinal fasciculus and inferior fronto-occipital fasciculus); RPLIC, Right Posterior limb internal capsule; RST, Right stria terminalis; GCC, Genu
of corpus callosum; SCC, Splenium of corpus callosum; RPCR, Right posterior corona radiata; RPTR*, Right posterior thalamic radiation (plus optic radiation); LPCR, Left posterior
corona radiata; RRIC, Right retro-lenticular internal capsule; LRLIC, Left retro-lenticular internal capsule, RALIC, Right anterior limb of internal capsule; LPLIC, Left posterior limb of
internal capsule.
infants show rapid change from 3–6 months of age followed
by slower change until 24 months. At 48 months of age, FA
color maps seems almost identical to the ones observed in adults
(29). This underscores the importance of timely imaging and
clinical diagnosis of ASD patients with early implementation of
interventional therapies. It is noteworthy tomention that patients
evaluated at G1 and G2 had a mean age of 2.9 and 4.2 years,
respectively. Thus, minor differences are to be expected because
of the slow rate of neurodevelopmental maturation of neural
tracts between 2–5 years of age. So far, a clear increase in FA
in multiple tracts post-therapy (Figure 2C) was observed. We
hypothesize that the early implementation of ABA, occupational,
psychomotor and speech therapies aid in brain development and
clinical outcome of G2 patients. This is demonstrable by the
significant increase in VB-MAPP scores at 6 months and 12
months post-therapies (Figure 1A).
Based on ASD symptoms at diagnosis including delayed
or absent speech, poor social communication skills, obsessive
behavior, restricted interests, hypersensitivity to sound, light,
and other sensory stimulation, TBSS ROI and fiber analysis
results of decreased FA and increased RD in the inferior
fronto-occipital fasciculus (IFOF) and uncinate fasciculus are
expected (Table 2). The IFOF connects ventral occipital lobe and
orbitofrontal cortex, and participates in reading, attention and
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FIGURE 2 | (A) TBSS analysis of major WM tracts illustrating significant regional fractional anisotropy (FA) decreases (>5%, p < 0.05) shown in red between
pre-therapy ASD patients(G1) and control subjects in the left (L) and right (R) uncinate fasciculus, left and right inferior fronto-occipital fasciculus, right superior
longitudinal fasciculus, forceps minor, left superior fronto-occipital fasciculus left and right anterior corona radiata, left external capsule, and right superior longitudinal
fasciculus. (B) TBSS analysis of major WM tracts, illustrating regional radial diffusivity (RD) increases (>5%, p < 0.05) shown in blue between G1 and control patients
in forceps minor, left superior fronto-occipital fasciculus, right inferior fronto-occipital fasciculus, left and right uncinate fasciculi, right superior longitudinal fasciculus
(temporal part), right superior longitudinal fasciculus, left and right anterior corona radiata, and left external capsule. (C) TBSS analysis of the major WM tracts,
illustrating regional fractional anisotropy (FA) increases (>5%, p < 0.05) shown in blue between G1 and G2 patients in left and right superior longitudinal fasciculi, left
and right inferior fronto-occipital fasciculi, left and right corticospinal tracts, left and right anterior thalamic radiations, forceps major, forceps minor, left external
capsule, left and right anterior and posterior corona radiata, right sagittal stratum, left and right posterior and anterior limbs of internal capsule, left cerebral peduncle,
right fornix cres, stria terminalis, splenium, genu, and body of the corpus callosum.
visual processing (32), whereas the uncinate fasciculus is part
of the limbic system involved in emotional processing, memory
and language functions (32). The FA increase after 12 months of
therapy suggests improved myelination and development of the
IFOF (Table 3).
In contrast, FA increase and RD decrease in the corona
radiata when comparing G1 and G2 patients. The corona radiata
regroups fibers transiting from thalamus to cerebral cortex and
from fronto-parietal cortex to the subcortical nuclei and then to
spinal cord and these form the backbone of perceptual, motor
and higher cognitive functions (32). These results underscore the
effectiveness of ABA/other interventional therapies and positive
impact on motor and perceptual functions controlled by the
above-mentioned tracts and regions.
The superior longitudinal fasciculus (SLF) and its connections
with cortical regions are involved in language comprehension
(Wernicke’s area) and production (Broca’s area). Studies
addressed this tract in children with language delay, a prime
symptom in ASD (33). RD was higher in ASD in the right SLF.
After 12 months of speech therapy, FA was higher in the SLF in
patients compared to themselves before therapy, similarly echoed
by improvement in VB-MAPP scores.
The corpus callossum (CC) enables communication between
both hemispheres. The CC has been linked to motor skills,
working memory, complex information, and speed processing
(5). FA decrease in the CC of ASD patients with increase in
FA after therapy, may indicate WM deficits causing impaired
cortical connectivity between the two hemispheres and less
axonal myelination at diagnosis with improvement after ABA
and other therapies. DTI revealed rapid and highly significant
changes in normal brain maturation with a significant increase
in FA in the genu of the CC from 0 to 2 years vs. 2–5 years (31).
Whereas, FA values of the splenium of the CC show no significant
changes after 2 years of age (31). Knowing that patients with
G2 scans have a median age of 4.2 years, reported DTI results
and patient clinical improvement confirms the positive impact
of interventional therapies on WM tract integrity and clinical
outcomes. The abnormalities in WM structure provide a neural
basis for disrupted systems-level connectivity in ASD (5, 34).
One of the components of the VB-MAPP is the Milestones
Assessment, which provides a representative sample of a child’s
existing verbal and related skills. The assessment includes
170 measurable learning and language milestones that are
sequenced and balanced across three developmental levels. Level
1, level 2, and level 3 each h consisting of nine developmental
communicative milestones are designed to approximately
correspond with the learning and language skills demonstrated
by children 0–18 months old, 18–30 months old, and children
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FIGURE 3 | Progress of scores in four VB-MAPP elements assessing the toddlers/pre-schooler ASD milestones at the time of diagnosis, after 6 and 12 months of
early interventional treatment. (A) Mand reflects if the child has absent, weak, or impaired mand repertoire, in other words “Does the child use words, signs, or
pictures to ask for desired items or activities?” (B) Listener reflects if the child has absent, weak, or impaired listener repertoires; “Does the child attend to and respond
to the words spoken by others?” (C) Visual section shows if there is any visual or impaired perceptual skills and matching-to-sample; “Does the child attend to and
respond to visual stimuli and match objects or pictures?” (D) Play component shows the state of the social and behavioral skills in playing; “Does the child attend to
others and attempt to socially engage others?”.
30–48 months of age, respectively (18). In this study 150
milestones were measured in total. Two elements of the VB-
MAPP measuring a maximum of 20 points (mainly “Echoic”
and “Group”) could not be measured. Patients at baseline with
a mean age of 2.7 years scored an average of 17.5 ± 14.5
points in their assessment, which corresponds to presence of
neuro-developmental delay (reference score = 90 points) thus
explaining DTI analysis results in G1 scans compared to controls.
After 6 months of ABA and interventional therapies, ASD
patients scored an average of 34.1 ± 23.9 points. Although far
from the reference score (150 points), progress was documented.
Twelve months after therapy, patients scored an average of
55.5 ± 30 points on the VB-MAPP which corresponds to
∼37% of the maximum score obtainable at this age. It is
worth noting that a huge difference in progress between one
ASD child and another will be encountered due to the fact
that environmental, genetic, and IQ factors can affect their
advancement. The significant progress of VB-MAPP scores in
each element of the assessment per child was obvious. The
improvement of four important elements of the test are pictured
in Figure 3. The progress in VB-MAPP scores was of great
value to emphasize the role of early interventional therapies
and ABA on clinical improvement in different fields and the
development of WM integrity in autistic children in addition to
normal physiological development.
METHODOLOGICAL STRENGTH AND
LIMITATIONS
This is a pilot study and the obtained results are preliminary
results. Plans are to continue this longitudinal study and to
achieve a higher sample size. The originality of this study relies
in being the first of its kind emphasizing the impact of ABA and
other interventional therapies on neuroanatomical and clinical
improvement of ASD patients using sequential DTI and VB-
MAPP assessments over 12-months. Although sample size was
small, in light of the young age of participants (1.8–5 years),
groups were age and sex matched and clinically similar. In
other words, we have carefully considered and ruled out the
possibility that group differences were attributable to age and
sex. Due to the rare incidence of encountered ASD patients and
ethical considerations and the importance of early intervention
in ASD, it was not possible to include an additional group of
ASD patients not receiving therapies. Future studies will focus
on comparing ASD patients after therapy with age-sex matched
ASD patients diagnosed at older age and not having received
therapies. Due to ethical limitations, scanning control subjects
twice with, no valid medical indication was not undertaken.
Also, cultural and economic reasons precluded multiple hospital
visits for patients and families. Although rare, adverse effects of
deep sedation related to ventilation including apnea, desaturation
Frontiers in Neurology | www.frontiersin.org 8 August 2019 | Volume 10 | Article 877
Saaybi et al. WM Integrity in Autism
and obstruction, vomiting and aspiration are encountered in
medical practice. Thus, to reduce or keep such complications
at a minimum excessive sedation was avoided. On the other
hand, age-matched controls were used at the outset to control
for differences in results not being caused by age and sex
differences. Similarly, recruiting older neuro-typical controls
can be a future goal. Ideally, a higher number of participants
would have allowed assessing effect on individual sub-scales of
VB-MAPP in males and females after early interventional and
ABA therapies.
CONCLUSION
In conclusion, findings highlight WM abnormalities in ASD
at diagnosis and confirm the benefits of ABA therapy and
early intervention on clinical and neuro imaging outcomes after
12 months. DTI is recommended as a complimentary tool to
supplement clinical assessments and aids in monitoring response
of ASD to traditional and emerging therapies.
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particularly important when analyzing the development of the
brain in toddlers growing into preschoolers. The results obtained
may therefore not be adopted. Nonetheless, the reported DTI
results in supplementary data support the effect of ABA and
early interventional therapy and are concordant with ASD
patients’ significant clinical improvement as measured by the
VBMAP scores.
Figure S1 | TBSS analysis of the major WM tracts, illustrating regional axial
diffusivity (AD) decreases (>5%, p < 0.05) shown in red between post-therapy
ASD patients (G2) and control subjects in left (L) superior longitudinal fasciculus,
right (R) superior corona radiata, right retro-lenticular part of internal capsule and
the body of the corpus callosum.
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